Lv31
310 积分 2023-07-06 加入
Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A multi-cohort, Basket, Phase II Trial (CABATEN/GETNE-T1914)
6小时前
待确认
MEN1 mutations mediate clinical resistance to menin inhibition
8小时前
已完结
Menin Loss in Pheochromocytoma of Multiple Endocrine Neoplasia Type 1
11小时前
已完结
Genotype-phenotype correlation in multiple endocrine neoplasia type 1
3天前
已完结
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia
4天前
已完结
Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice
5天前
已完结
Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations
1个月前
已完结
Association of primary hyperparathyroidism with pituitary adenoma and management issues
1个月前
已关闭
MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations
1个月前
已关闭
皖公网安备34019202002308
